Evidence map›Paper›PMID 42272987›Full record

ArticleComputer speech & language2026

Towards decoupling frontend enhancement and backend recognition in monaural robust ASR.

Yufeng Yang, Ashutosh Pandey, DeLiang Wang

Abstract read
In one paragraph

Article in Computer speech & language, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yufeng YangDepartment of Computer Science and Engineering, The Ohio State University, 2015 Neil Avenue, Columbus, 43210, OH, United States.ORCID 0000-0001-5921-6541
Ashutosh PandeyDepartment of Computer Science and Engineering, The Ohio State University, 2015 Neil Avenue, Columbus, 43210, OH, United States.
DeLiang WangDepartment of Computer Science and Engineering, The Ohio State University, 2015 Neil Avenue, Columbus, 43210, OH, United States.

Funding

Speech segregation to improve intelligility of reverberant-noisy speechR01DC012048 · NIDCD · OHIO STATE UNIVERSITY · PI WILLIAMSON, DONALD · 2013 to 2022
$3.3M
NIDCD NIH HHS R01 DC012048
6 · The paper itself

Abstract

It has been shown that the intelligibility of noisy speech can be improved by speech enhancement (SE) algorithms. However, monaural SE has not been established as an effective frontend for automatic speech recognition (ASR) in noisy conditions compared to an ASR model trained on noisy speech directly. The divide between SE and ASR impedes the progress of robust ASR systems, especially as SE has made major advances in recent years. This paper focuses on eliminating this divide with an ARN (attentive recurrent network) time-domain, a TF-CrossNet time-frequency domain, and an MP-SENet magnitude-phase based enhancement model. The proposed systems decouple frontend enhancement and backend ASR, with the latter trained only on clean speech. Results on the WSJ, CHiME-2, LibriSpeech, and CHiME-4 corpora demonstrate that ARN, TF-CrossNet, and MP-SENet enhanced speech all translate to improved ASR results in noisy and reverberant environments, and generalize well to real acoustic scenarios. The proposed system outperforms the baselines trained on corrupted speech directly. Furthermore, it cuts the previous best word error rate (WER) on CHiME-2 by 28.4% relatively with a 5.6% WER, and achieves 3.3/4.4% WER on single-channel CHiME-4 simulated/real test data without training on CHiME-4. We also observe consistent improvements using noise-robust Whisper as the backend ASR model.

Indexed as

CHiME-2CHiME-4Robust ASRSpeech distortionSpeech enhancement

Identifiers

PMID42272987
PMCPMC13249453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.